How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recursion Pharmaceuticals logged 5 insider transactions totaling $514,889.42. Activity was led by 4 tax payments worth $436,067.04 and 1 sale worth $78,822.38. Ben R Taylor recorded 2 tax payments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results